Clinical Trial Market Research Reports & Industry Analysis

Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in axSpA therapeutics. Synopsis In 2022, there will be more than 10.7 million diagnos ...

Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035 Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even fail altogethe ...

Small Bone And Joint Devices Market Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030 Market Analysis and Insights The Global Clinical Trials Management System Market Analysis report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restrai ...

Anti Vegf Therapeutics Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030 Market Analysis and Insights The Global Artificial Intelligence Based Clinical Trials Solution Provider Market Analysis report covers comprehensive data on emerging trends, market drivers ...

Global Neuroendocrine Cancer Market - 2022-2029 Market Overview The Neuroendocrine Cancer Market size was valued at USD million in 2021 and is estimated to reach USD million by 2029, growing at a CAGR of 10.6% during the forecast period (2022-2029). Neuroendocrine tumors are tumors that start in spe ...

Global Glioblastoma Multiforme Market - 2022-2029 Market Overview Glioblastoma Multiforme Market is expected to grow at a high CAGR of 8.8% during the forecasting period (2022-2029). Glioblastoma multiforme (GBM) is a malignant type of central nervous system tumor. Globally, GBM accounts for 54% of ...

Global Skin Cancer Market - 2022-2029 Market Overview Skin Cancer Market is expected to grow at a CAGR 8% during the forecasting period (2022-2029). Skin cancer is the most common type of cancer caused due to abnormal growth of skin cells. It is estimated that 90% of skin cancer is caused majorly du ...

Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Asthma therapeutics. Synopsis In 2022, there will be more than 260.6 million diagnosed prevalent cases of A ...

MarketVue®: Netherton’s Syndrome The MarketVue®: Netherton’s Syndrome market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US ...

Global Red Biotechnology Market - 2022-2029 Market Overview Red Biotechnology Market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5.2% during the forecast period (2022-2029). Red biotechnology indicates biopharmaceuticals. It involv ...

Pediatric Clinical Trials Market, by Clinical Trial Phase (Pre-clinical, Phase I, Phase II, and Phase III), by Study Design (Treatment Studies and Observational Studies), by Medical Condition (Neuropsychiatric Conditions, Infectious Diseases, Maternal and Perinatal Conditions, Respiratory Diseases, ...

Clinical Trials - The Movement Towards Decentralized Clinical Trials Summary This report provides an analysis on DCT's/Virtual trials. Key Highlights DCT usage is on the rise North America has conducted the most DCTs Mobile Healthcare is the top virtual component used Scope The clinical trial data u ...

Middle East & Africa Pharma ADMET Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Applicati ...

North America Pharma ADMET Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Sys ...

Pharmaceutical Drugs Industry: Global Competitive Landscape 2021 Report Scope : This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles ...

U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029 U.S. Real-World Evidence (RWE) Solutions Market by Component [Datase ...

Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Autoimmune Hepatitis therapeutics. Synopsis In 2022, there will be more than 36.000 diagnose ...

AI-based Clinical Trial Solutions For Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030 AI-based Clinical Trial Solutions For Patient Matching Market Growth & Trends The global AI-based clinical trial so ...

Global Clinical Trial Management Systems (CTMS) Market 2022 - Snapshot In 2021, the global CTMS market stood at USD 944 million. Recording a CAGR of 11.6% from 2022 to 2028, the worth is projected to reach ~USD 2,035 million by 2028, according to a new report by Gen Consulting Company. This industry ...

Global Clinical Trial Imaging Market - Industry Trends and Forecast to 2029 The global clinical trial imaging market is projected to register a substantial CAGR of 8.1% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculatio ...

MEA Clinical Trial Imaging Market - Industry Trends and Forecast to 2029 Middle East and Africa clinical trial imaging market is projected to register a substantial CAGR of 6.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of c ...

Europe Clinical Trial Imaging Market - Industry Trends and Forecast to 2029 Europe clinical trial imaging market is projected to register a substantial CAGR of 7.9% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is ...

APAC Clinical Trial Imaging Market - Industry Trends and Forecast to 2029 Asia-Pacific clinical trial imaging market is projected to register a substantial CAGR of 8.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculatio ...

NA Clinical Trial Imaging Market - Industry Trends and Forecast to 2029 North America clinical trial imaging market is projected to register a substantial CAGR of 8.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation ...

Rare Kidney Disorders Market, 2022-2035 The term rare kidney diseases represents around 150 different indications. It is worth highlighting that the prevalence rate of rare kidney disorders (RKD) is estimated to be 60-80 per 100,000 cases / individuals in the US and Europe. Despite their relatively ...